Showing results (141-150 of 167) with videos related to
Sort By:
Pageof 17
Lancet (London, England)|April 16, 2023
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trialBrett King, Xingqi Zhang, Walter Gubelin Harcha, et al.The Journal of Dermatology|September 27, 2024
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalisNatasha Mesinkovska, Brett King, Xingqi Zhang, et al.International Journal of Dermatology|February 12, 2016
Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trialsBruce Strober, Bárður Sigurgeirsson, Georg Popp, et al.Journal of the American Academy of Dermatology|April 5, 2023
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areataCheng Zhou, Xiumin Yang, Bin Yang, et al.Clinical and Experimental Dermatology|October 9, 2025
A multicentre cohort study of the clinicopathological features and treatment outcomes of fibrosing alopecia in a pattern distributionGia Toan Tang, Daranporn Triwongwaranat, Marcelo de Souza Teixeira, et al.Immunotherapy|November 15, 2021
Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summaryThomas Bieber, Eric L Simpson, Jonathan I Silverberg, et al.The New England Journal of Medicine|March 24, 2021
Abrocitinib versus Placebo or Dupilumab for Atopic DermatitisThomas Bieber, Eric L Simpson, Jonathan I Silverberg, et al.The Australasian Journal of Dermatology|September 30, 2025
Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus StatementDaniella Kushnir-Grinbaum, Laita Bokhari, John Frewen, et al.International Journal of Dermatology|February 16, 2026
Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia-Pacific Modified Delphi Expert Panel RecommendationsRodney Sinclair, Chao-Chun Yang, Wen-Hung Chung, et al.Journal of the American Academy of Dermatology|November 12, 2022
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trialKhaled Ezzedine, Elena Peeva, Yuji Yamaguchi, et al.Pageof 17